Literature DB >> 823724

[Influence of nitroglycerin on hemodynamics, wall tension and oxygen consumption of the left ventricle].

G Sauer, J Jehle, R Karsch, H Kreuzer, K L Neuhaus, P Spiller.   

Abstract

The effects of nitroglycerin on left ventricular hemodynamics were determined in ten patients from biplane cineventriculograms and simultaneous pressure measurements. Before and after nitroglycerin (1.6 mg sublingually) the following parameters were measured: Systolic (PLV) and enddiastolic pressure (PLVED), enddiastolic (EDV) und endsystolic volume (ESV), cardiac output (SV), ejection fraction (EF) and ejection rate (ER), ejection time (tej), heart rate (HR), dp/dtmax, dp/dtmax Pi-Ped, maximal systolic wall stress (sigmamax), integrated systolic wall stress (sigma), outflow resistance (Rsys) and ventricular compliance (a). Nitroglycerin leads to a reduction of both, pre- and afterload, with a significant fall of PLV (10.8%), PLVED (21.8%), EDV (9.1%) ESV (13.3%) AND Rsys (14.4%). The changes of ventricular pressure and geometry result in a diminution of left ventricular wall stress (sigmamax- 11.8%, sigma - 26.4%), representing a decrease of calculated total oxygen-consumption of 11.5%. In six patients with reduced left ventricular diastolic compliance nitroglycerin leads to a remarkable increase of the compliance. This is probably due to the reversal of a latent ischemia by the decreased myocardial oxygen-consumption.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823724

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  2 in total

1.  Effects of nitroglycerin on the circulatory system, myocardial dynamics and left ventricular oxygen consumption in the anesthetized beagle-dog.

Authors:  C F Cartheuser; J Komarek
Journal:  Basic Res Cardiol       Date:  1979 Mar-Apr       Impact factor: 17.165

Review 2.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.